AXIM Biotechnologies News

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

21.03.17	Medical Marijuana, Inc. Investment AXIM Biotech Retains Ora To Manage Upcoming Product Development And Clinical Trials On Glaucoma And Dry Eye Indications (PR Newswire)
15.03.17	Biotech Innovations Drive Cannabinoid-Based Pharmaceutical Market Growth (PR Newswire)
14.03.17	The Growth in Legal Cannabis Market Sales (PR Newswire)
14.03.17	Biotech Influence in Exploding Cannabis Industry Boosting Innovative Treatments and Therapies (PR Newswire)
14.03.17	Biotech Influence in Exploding Cannabis Industry Boosting Innovative Treatments and Therapies (PR Newswire)
07.03.17	Medical Marijuana, Inc. Investment AXIM® Biotech annonce que les patients inscrits entament la phase 2 de l'etude pour le traitement du syndrome du colon irritable (SCI) avec le chewing-gum CanChew... (PR Newswire)
07.03.17	Medical Marijuana, Inc.'s Investmentgesellschaft AXIM® Biotech verkündet Beginn der Phase-II-Studie mit rekrutierten Patienten zur Behandlung des Reizdarmsyndroms (RDS) mit CanChew Plus®... (PR Newswire)
07.03.17	Medical Marijuana, Inc. Investment AXIM® Biotech Announces Enrolled Patients Begin Phase II Trial For The Treatment Of Irritable Bowel Syndrome (IBS) With CanChew Plus® Cannabidiol (CBD) Chewing Gum (PR Newswire)
07.03.17	Medical Marijuana, Inc. Investment AXIM® Biotech Announces Enrolled Patients Begin Phase II Trial For The Treatment Of Irritable Bowel Syndrome (IBS) With CanChew Plus® Cannabidiol (CBD) Chewing Gum (PR Newswire)
19.01.17	Medical Marijuana, Inc.'s Investmentgesellschaft AXIM® Biotech beginnt klinische RDS-Studie mit CBD-Kaugummi (PR Newswire)
19.01.17	La société d'investissement AXIM® Biotech de Medical Marijuana, Inc. entre en phase d'essai clinique pour le syndrome du côlon irritable avec un chewing-gum à base de CBD (PR Newswire)
19.01.17	Medical Marijuana, Inc. Investment AXIM® Biotech Enters IBS Clinical Trial With CBD Chewing Gum (PR Newswire)
19.01.17	Medical Marijuana, Inc. Investment AXIM® Biotech Enters IBS Clinical Trial With CBD Chewing Gum (PR Newswire)
19.01.17	Medical Marijuana, Inc. Investment AXIM® Biotech Enters IBS Clinical Trial With CBD Chewing Gum (PR Newswire)
12.01.17	Cannabis Stocks Positioning to Regain Momentum in 2017 (PR Newswire)
06.12.16	Rising Global Demand for Cannabis Products and Grow Equipment Continues to Drive Legal Marijuana Opportunity (PR Newswire)
22.11.16	Cannabis Stocks Revenue Opportunities Boosted by Asset Acquisitions, Product Development (PR Newswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V